The UK pharma’s ageing Advair inhaler, still a mainstay of GSK's respiratory portfolio, is threatened by generic competition ... obstruction in patients with COPD, including chronic bronchitis ...

Teva has launched new digital inhaler ... generic version of GlaxoSmithKline’s blockbuster inhaler Advair (fluticasone+salmeterol). The competition for the product approved in asthma and COPD ...